COVID-19 Rapid Letter

Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic☆

The Editors of the Journal, the Publisher and the European Society for Radiotherapy and Oncology (ESTRO) cannot take responsibility for the statements or opinions expressed by the authors of these articles. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. For more information see the editorial “Radiotherapy & Oncology during the COVID-19 pandemic”, Vol. 146, 2020.

On behalf of all coauthors of the ESTRO ASTRO practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic.